Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
| Autor: | Clement, P.M. *, Gauler, T., Machiels, J.P., Haddad, R.I., Fayette, J., Licitra, L.F., Tahara, M., Cohen, E.E.W., Cupissol, D., Grau, J.J., Guigay, J., Caponigro, F., de Castro, G., Jr, de Souza Viana, L., Keilholz, U., del Campo, J.M., Cong, X.J., Ehrnrooth, E., Vermorken, J.B. |
|---|---|
| Zdroj: | In Annals of Oncology August 2016 27(8):1585-1593 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|